Concepedia

Gabriel A. Magariños

GA

Statistics

Publications

2

Citations

151

H-Index

2

Active since

2020

Affiliations

Probity Medical Research(Current)

Northwestern University

Eli Lilly (United States)

Radboud University Medical Center

Goethe University Frankfurt

Gabriel A. Magariños is an author at Probity Medical Research specializing in pediatric dermatology, psoriasis therapy, and medicine.

Publications per year

2020–2022

2

Publications

2

Efficacy and safety of ixekizumab in a phase <scp>III</scp> , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( <scp>IXORA</scp> ‐ <scp>PEDS</scp> )

Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños et al. · British Journal of Dermatology · 2020 · 108 citations · Full text

, , +11

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños et al. · JAMA Dermatology · 2022 · 43 citations · Full text

, , +13

1–2 of 2